PRVL
Barclays’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,778
| Closed | -$110K | – | 4033 |
|
|
2020
Q4 | $110K | Sell |
4,778
-26,847
| -85% | -$618K | ﹤0.01% | 2954 |
|
|
2020
Q3 | $322K | Buy |
31,625
+14,493
| +85% | +$148K | ﹤0.01% | 2518 |
|
|
2020
Q2 | $255K | Buy |
17,132
+7,216
| +73% | +$107K | ﹤0.01% | 2676 |
|
|
2020
Q1 | $121K | Buy |
9,916
+2,352
| +31% | +$28.7K | ﹤0.01% | 2752 |
|
|
2019
Q4 | $119K | Buy |
7,564
+3,761
| +99% | +$59.2K | ﹤0.01% | 3394 |
|
|
2019
Q3 | $47K | Buy |
+3,803
| New | +$47K | ﹤0.01% | 3700 |
|